RenovoRx RNXT
NASDAQ RNXT
$1.27 +0.00 (+0.00%)
As of: Oct 23, 2026 · 3:01 PM EDT

RenovoRx (RNXT) Amortization of Deferred Charges (2020 - 2021)

Updated

Analysis

RenovoRx (RNXT) Amortization of Deferred Charges (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.33 Bn 228.36 Bn 4.88 Bn
2 Abbott Laboratories 180.57 Bn 151.00 Bn 7.27 Bn
3 Danaher 160.65 Bn 144.46 Bn 3.61 Bn
4 Intuitive Surgical 157.85 Bn 138.14 Bn 2.08 Bn
5 Medtronic 122.62 Bn 87.87 Bn 6.34 Bn
6 Stryker 118.19 Bn 104.30 Bn 4.50 Bn
7 Boston Scientific 67.03 Bn 61.79 Bn 3.85 Bn
8 Becton Dickinson 54.83 Bn 51.98 Bn 2.32 Bn
9 Edwards Lifesciences 51.57 Bn 35.58 Bn 1.35 Bn
10 RenovoRx 60.07 Mn 21.10 Mn 766,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 159,000.00
Jun 30, 2021 350,000.00
Mar 31, 2021 188,000.00
Dec 31, 2020 136,000.00
API Access

RenovoRx Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=RNXT&period=max&api_key=YOUR_API_KEY